The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells

Pioglitazone (PGZ) is a prescription drug used in the treatment of diabetes mellitus type II. It is a well-known synthetic agonist for PP AR, and being studied extensively by our research group as a target drug for the treatment of ER-negative breast cancer. The ER-negative breast cancer is more...

Full description

Saved in:
Bibliographic Details
Main Author: Nadarajan, Kalpanah
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://eprints.usm.my/56796/1/00001792017%20Kalpanah%20a.p%20Nadarajan.pdf
http://eprints.usm.my/56796/
Tags: Add Tag
No Tags, Be the first to tag this record!